Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Total Costs & Expenses
$9.99M
Quarterly · Period ending: · USD

LCTX Total Costs & Expenses
Latest reported$9.99Mperiod ending
Latest reported$9.99Mperiod ending
LCTX Quarterly Total Costs & Expenses ($200.00K → $9.99M)
Quarterly Total Costs & Expenses
High-resolution chart · PNG
LCTX total costs & expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Costs & Expenses (USD) |
|---|---|
| 9,992,000 | |
| 9,318,000 | |
| 13,156,000 | |
| 7,467,000 | |
| 22,545,000 | |
| 8,007,000 | |
| 7,978,000 | |
| 7,619,000 | |
| 7,275,000 | |
| 8,105,000 | |
| 8,450,000 | |
| 7,951,000 | |
| 8,249,000 | |
| 9,028,000 | |
| 8,554,000 | |
| 8,249,000 | |
| 8,787,000 | |
| 11,633,000 | |
| 29,198,000 | |
| 9,045,000 | |
| 7,521,000 | |
| 7,343,000 | |
| 6,048,000 | |
| 7,067,000 | |
| 6,501,000 | |
| 7,604,000 | |
| 7,704,000 | |
| 8,639,000 | |
| 11,071,000 | |
| 12,940,000 | |
| 10,278,000 | |
| 10,621,000 | |
| 9,750,000 | |
| 11,762,000 | |
| 10,132,000 | |
| 9,976,000 | |
| 10,699,000 | |
| 11,641,000 | |
| 12,011,000 | |
| 9,945,000 | |
| 14,909,000 | |
| 24,344,000 | |
| 22,255,000 | |
| 17,944,000 | |
| 14,068,000 | |
| 14,067,638 | |
| 14,848,795 | |
| 12,681,112 | |
| 13,528,340 | |
| 11,628,819 | |
| 13,095,059 | |
| 10,755,584 | |
| 8,639,296 | |
| 8,904,056 | |
| 7,576,499 | |
| 6,950,109 | |
| 7,112,995 | |
| 6,547,486 | |
| 7,091,367 | |
| 5,375,419 | |
| 5,736,547 | |
| 4,850,516 | |
| 5,173,949 | |
| 3,272,988 | |
| 2,995,702 | |
| 2,093,249 | |
| -984,502 | |
| 3,381,334 | |
| 1,539,740 | |
| 1,207,998 | |
| 1,253,303 | |
| 1,340,784 | |
| 1,359,899 | |
| 788,090 | |
| 615,918 | |
| 386,825 | |
| 504,539 | |
| 761,330 | |
| 820,205 | |
| 606,486 | |
| 784,375 | |
| 702,813 | |
| 684,422 | |
| 644,132 | |
| 676,448 | |
| 916,609 | |
| 791,334 | |
| 586,338 | |
| 643,281 | |
| 636,198 | |
| 626,583 | |
| 467,192 | |
| 590,171 | |
| 562,304 | |
| 792,131 | |
| 403,440 | |
| 634,100 | |
| 591,978 | |
| 485,823 | |
| 970,505 |